Gayathri Thirumalaiselvan, MD
Internal Medicine · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 2 carriers
- Offices
- 2
Offices
2 locations · Seema Sangwan MD Inc A California Professional Corporation · 3 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
15 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Thirumalaiselvan’s office at (408) 900-8077 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A102994 · Current
Licensed to practise in California · since 2008 · expires 2027-04-30 · Dr. M.G.R. Medical University Chennai Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$10,252
Medicare paid this office $10,252 for 40 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 17 | $2,609 | $87 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $1,222 | $76 |
| New patient visit (30+ min) | 11 | $1,178 | $107 |
Who their Medicare patients are
40 Original Medicare patients in 2024. Average age 75 · Under 65 0% · Women 70% · Health risk score 0.95. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 68% · Diabetes 33%.
The office billed $25,113, Medicare allowed $12,037 and paid $10,252; for 98 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 40 | 98 | 75 | 0.95 | $25,113 | $10,252 |
| 2023 | 17 | 70 | 74 | 1.23 | $13,834 | $5,896 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Drugs they prescribed that Part D paid
$23,949
Pharmacies billed $23,949 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 402) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
367 generic and 35 brand-name prescriptions · $23,949 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Metoprolol | 14 | $875 | $62 |
| Tamsulosin | 16 | $629 | $39 |
| Atorvastatin | 38 | $432 | $11 |
| Losartan | 31 | $352 | $11 |
| Amlodipine Besylate | 28 | $282 | $10 |
See all 8 drugs
| Metoprolol | 14 | $875 | $62 |
| Tamsulosin | 16 | $629 | $39 |
| Atorvastatin | 38 | $432 | $11 |
| Losartan | 31 | $352 | $11 |
| Amlodipine Besylate | 28 | $282 | $10 |
| Levothyroxine | 18 | $180 | $10 |
| Rosuvastatin | 17 | $168 | $10 |
| Alendronate | 11 | $52 | $5 |
Year by year
| 2024 | 402 | 73 | 0% (0) | 9% | $23,949 |
| 2023 | 217 | 64 | 0% (0) | None | $14,425 |
| 2022 | 893 | 191 | 2% (15) | None | $41,143 |
| 2021 | 1,847 | 299 | 3% (52) | 10% | $93,559 |
| 2020 | 1,744 | 248 | 3% (50) | 12% | $97,998 |
| 2019 | 1,768 | 292 | 3% (56) | 11% | $89,794 |
| 2018 | 2,209 | 353 | 3% (69) | 16% | $105,261 |
| 2017 | 2,386 | 276 | 1% (33) | 17% | $111,380 |
| 2016 | 2,384 | 282 | 3% (66) | 20% | $113,867 |
| 2015 | 2,390 | 276 | 3% (68) | 23% | $119,432 |
| 2014 | 2,320 | 262 | 5% (104) | 18% | $90,728 |
| 2013 | 2,276 | 270 | 5% (104) | 21% | $107,554 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Losartan | 14 | $278 | $20 |
| Amlodipine Besylate | 20 | $242 | $12 |
| Atorvastatin | 14 | $221 | $16 |
| Levothyroxine | 11 | $215 | $20 |
| Alendronate | 15 | $188 | $13 |
2022: 23 drugs
| Spiriva Respimat | 14 | $10,026 | $716 |
| Pradaxa | 13 | $8,292 | $638 |
| Levothyroxine | 46 | $1,074 | $23 |
| Atorvastatin | 65 | $780 | $12 |
| Gabapentin | 34 | $771 | $23 |
| Simvastatin | 62 | $703 | $11 |
| Losartan | 45 | $662 | $15 |
| Hydralazine | 13 | $660 | $51 |
| Amlodipine Besylate | 43 | $530 | $12 |
| Lisinopril | 35 | $506 | $14 |
| Fluticasone Propionate | 26 | $440 | $17 |
| Losartan-Hydrochlorothiazide | 11 | $374 | $34 |
| Alendronate | 32 | $328 | $10 |
| Atenolol | 26 | $326 | $13 |
| Lisinopril-Hydrochlorothiazide | 25 | $326 | $13 |
| Hydrochlorothiazide | 27 | $295 | $11 |
| Furosemide | 17 | $248 | $15 |
| Tamsulosin | 11 | $169 | $15 |
| Glipizide | 11 | $165 | $15 |
| Lovastatin | 14 | $163 | $12 |
| Metoprolol | 17 | $156 | $9 |
| Famotidine | 11 | $117 | $11 |
| Metformin Hcl Er | 11 | $75 | $7 |
2021: 41 drugs
| Pradaxa | 26 | $18,172 | $699 |
| Spiriva Respimat | 25 | $17,939 | $718 |
| Wixela Inhub | 14 | $3,547 | $253 |
| Fentanyl | 11 | $2,332 | $212 |
| Levothyroxine | 102 | $2,310 | $23 |
| Gabapentin | 56 | $1,797 | $32 |
| Atorvastatin | 130 | $1,641 | $13 |
| Alvesco | 14 | $1,532 | $109 |
| Losartan | 95 | $1,318 | $14 |
| Hydralazine | 21 | $1,191 | $57 |
| Simvastatin | 104 | $1,165 | $11 |
| Amlodipine Besylate | 76 | $968 | $13 |
| Ventolin Hfa | 16 | $932 | $58 |
| Lisinopril | 66 | $932 | $14 |
| Terazosin | 16 | $755 | $47 |
| Trazodone | 35 | $746 | $21 |
| Lisinopril-Hydrochlorothiazide | 52 | $627 | $12 |
| Alendronate | 60 | $624 | $10 |
| Hydrochlorothiazide | 57 | $624 | $11 |
| Atenolol | 60 | $609 | $10 |
| Hydrocodone-Acetaminophen | 31 | $599 | $19 |
| Losartan-Hydrochlorothiazide | 17 | $514 | $30 |
| Fluticasone Propionate | 34 | $510 | $15 |
| Diclofenac | 16 | $440 | $28 |
| Famotidine | 38 | $369 | $10 |
| Metoprolol | 35 | $348 | $10 |
| Veo Insulin | 11 | $320 | $29 |
| Furosemide | 25 | $313 | $13 |
| Tamsulosin | 16 | $289 | $18 |
| Metformin | 19 | $288 | $15 |
| Lovastatin | 23 | $272 | $12 |
| Glipizide | 18 | $248 | $14 |
| Clopidogrel | 15 | $241 | $16 |
| Finasteride | 15 | $234 | $16 |
| Allopurinol | 11 | $212 | $19 |
| Omeprazole | 13 | $202 | $16 |
| Fluoxetine | 12 | $193 | $16 |
| Ibuprofen | 12 | $184 | $15 |
| Carvedilol | 14 | $177 | $13 |
| Cephalexin | 13 | $132 | $10 |
| Metformin Hcl Er | 16 | $115 | $7 |
2020: 36 drugs
| Spiriva Respimat | 26 | $15,651 | $602 |
| Pradaxa | 21 | $14,624 | $696 |
| Advair Diskus | 33 | $8,289 | $251 |
| Levothyroxine | 94 | $2,669 | $28 |
| Fentanyl | 12 | $2,544 | $212 |
| Humulin N | 11 | $1,789 | $163 |
| Atorvastatin | 115 | $1,596 | $14 |
| Losartan | 114 | $1,456 | $13 |
| Ventolin Hfa | 28 | $1,435 | $51 |
| Gabapentin | 37 | $1,238 | $33 |
| Lisinopril | 81 | $1,114 | $14 |
| Simvastatin | 95 | $1,060 | $11 |
| Dilt-Xr | 11 | $877 | $80 |
| Amlodipine Besylate | 67 | $813 | $12 |
| Trazodone | 29 | $757 | $26 |
| Hydrochlorothiazide | 64 | $680 | $11 |
| Lisinopril-Hydrochlorothiazide | 57 | $646 | $11 |
| Hydrocodone-Acetaminophen | 35 | $639 | $18 |
| Fluticasone Propionate | 33 | $535 | $16 |
| Terazosin | 16 | $525 | $33 |
| Atenolol | 48 | $496 | $10 |
| Losartan-Hydrochlorothiazide | 14 | $430 | $31 |
| Nortriptyline | 15 | $422 | $28 |
| Metformin | 26 | $373 | $14 |
| Alendronate | 35 | $364 | $10 |
| Allopurinol | 13 | $356 | $27 |
| Metoprolol | 34 | $343 | $10 |
| Lovastatin | 27 | $320 | $12 |
| Glipizide | 23 | $288 | $13 |
| Veo Insulin | 12 | $281 | $23 |
| Tamsulosin | 13 | $233 | $18 |
| Furosemide | 18 | $224 | $12 |
| Famotidine | 29 | $219 | $8 |
| Carvedilol | 20 | $209 | $10 |
| Acyclovir | 11 | $119 | $11 |
| Metformin Hcl Er | 12 | $90 | $8 |
2019: 34 drugs
| Pradaxa | 20 | $12,888 | $644 |
| Spiriva Respimat | 18 | $11,345 | $630 |
| Advair Diskus | 15 | $7,167 | $478 |
| Levothyroxine | 88 | $2,585 | $29 |
| Atorvastatin | 110 | $2,471 | $22 |
| Fentanyl | 11 | $2,332 | $212 |
| Losartan | 122 | $1,465 | $12 |
| Lisinopril | 91 | $1,248 | $14 |
| Gabapentin | 38 | $1,168 | $31 |
| Amlodipine Besylate | 90 | $1,002 | $11 |
| Simvastatin | 79 | $857 | $11 |
| Ventolin Hfa | 17 | $819 | $48 |
| Atenolol | 63 | $752 | $12 |
| Hydralazine | 16 | $621 | $39 |
| Lisinopril-Hydrochlorothiazide | 58 | $583 | $10 |
| Metformin | 39 | $543 | $14 |
| Hydrocodone-Acetaminophen | 38 | $515 | $14 |
| Hydrochlorothiazide | 44 | $502 | $11 |
| Terazosin | 17 | $487 | $29 |
| Fluticasone Propionate | 28 | $447 | $16 |
| Lovastatin | 36 | $444 | $12 |
| Alendronate | 37 | $417 | $11 |
| Glipizide | 35 | $412 | $12 |
| Metoprolol | 38 | $370 | $10 |
| Trazodone | 30 | $360 | $12 |
| Allopurinol | 12 | $346 | $29 |
| Nortriptyline | 22 | $344 | $16 |
| Furosemide | 23 | $303 | $13 |
| Warfarin | 18 | $219 | $12 |
| Losartan-Hydrochlorothiazide | 15 | $188 | $13 |
| Famotidine | 15 | $171 | $11 |
| Carvedilol | 14 | $167 | $12 |
| Metformin Hcl Er | 17 | $158 | $9 |
| Azithromycin | 13 | $96 | $7 |
2018: 41 drugs
| Advair Diskus | 24 | $12,422 | $518 |
| Spiriva Respimat | 12 | $8,232 | $686 |
| Pradaxa | 14 | $7,589 | $542 |
| Humulin N | 17 | $3,690 | $217 |
| Atorvastatin | 139 | $3,382 | $24 |
| Levothyroxine | 96 | $2,830 | $29 |
| Losartan | 133 | $2,162 | $16 |
| Qvar | 13 | $1,733 | $133 |
| Lisinopril | 117 | $1,551 | $13 |
| Gabapentin | 42 | $1,405 | $33 |
| Simvastatin | 103 | $1,050 | $10 |
| Dilt-Xr | 16 | $1,020 | $64 |
| Atenolol | 83 | $1,003 | $12 |
| Ventolin Hfa | 21 | $971 | $46 |
| Amlodipine Besylate | 125 | $968 | $8 |
| Allopurinol | 28 | $961 | $34 |
| Lisinopril-Hydrochlorothiazide | 76 | $887 | $12 |
| Metformin | 54 | $767 | $14 |
| Hydralazine | 11 | $713 | $65 |
| Hydrochlorothiazide | 59 | $699 | $12 |
| Metoprolol | 66 | $681 | $10 |
| Terazosin | 29 | $615 | $21 |
| Furosemide | 41 | $611 | $15 |
| Hydrocodone-Acetaminophen | 43 | $583 | $14 |
| Nortriptyline | 31 | $519 | $17 |
| Lovastatin | 48 | $499 | $10 |
| Glipizide | 29 | $498 | $17 |
| Pravastatin | 19 | $493 | $26 |
| Alendronate | 36 | $453 | $13 |
| Trazodone | 29 | $386 | $13 |
| Famotidine | 19 | $339 | $18 |
| Fluticasone Propionate | 22 | $335 | $15 |
| Triamcinolone Acetonide | 20 | $331 | $17 |
| Veo Insulin | 16 | $294 | $18 |
| Ranitidine | 12 | $283 | $24 |
| Pramipexole Dihydrochloride | 11 | $282 | $26 |
| Tamsulosin | 12 | $275 | $23 |
| Carvedilol | 20 | $260 | $13 |
| Acyclovir | 11 | $212 | $19 |
| Metformin Hcl Er | 14 | $191 | $14 |
| Cephalexin | 17 | $172 | $10 |
2017: 40 drugs
| Pradaxa | 23 | $9,770 | $425 |
| Spiriva Respimat | 17 | $8,383 | $493 |
| Dulera | 14 | $5,825 | $416 |
| Levothyroxine | 128 | $4,042 | $32 |
| Atorvastatin | 147 | $3,874 | $26 |
| Humulin N | 24 | $3,864 | $161 |
| Losartan | 127 | $3,187 | $25 |
| Qvar | 24 | $2,298 | $96 |
| Hydralazine | 21 | $1,896 | $90 |
| Lisinopril | 125 | $1,559 | $12 |
| Simvastatin | 112 | $1,313 | $12 |
| Atenolol | 110 | $1,294 | $12 |
| Gabapentin | 27 | $1,232 | $46 |
| Dilt-Xr | 19 | $1,129 | $59 |
| Allopurinol | 33 | $1,103 | $33 |
| Lisinopril-Hydrochlorothiazide | 89 | $1,041 | $12 |
| Amlodipine Besylate | 122 | $999 | $8 |
| Metformin | 72 | $952 | $13 |
| Hydrochlorothiazide | 78 | $924 | $12 |
| Pravastatin | 28 | $770 | $27 |
| Hydrocodone-Acetaminophen | 30 | $647 | $22 |
| Nortriptyline | 43 | $641 | $15 |
| Metoprolol | 61 | $631 | $10 |
| Glipizide | 41 | $615 | $15 |
| Alendronate | 42 | $597 | $14 |
| Lovastatin | 54 | $595 | $11 |
| Fluticasone Propionate | 36 | $535 | $15 |
| Ventolin Hfa | 12 | $519 | $43 |
| Furosemide | 32 | $493 | $15 |
| Trazodone | 39 | $467 | $12 |
| Prednisone | 15 | $410 | $27 |
| Terazosin | 25 | $315 | $13 |
| Insulin | 16 | $298 | $19 |
| Famotidine | 19 | $269 | $14 |
| Carvedilol | 20 | $252 | $13 |
| Triamcinolone Acetonide | 14 | $248 | $18 |
| Cephalexin | 25 | $228 | $9 |
| Amoxicillin | 11 | $190 | $17 |
| Fluoxetine | 12 | $164 | $14 |
| Azithromycin | 15 | $118 | $8 |
2016: 46 drugs
| Aspirin-Dipyridamole Er | 12 | $10,068 | $839 |
| Spiriva Respimat | 17 | $6,356 | $374 |
| Levothyroxine | 129 | $4,738 | $37 |
| Pradaxa | 11 | $4,612 | $419 |
| Atorvastatin | 126 | $3,655 | $29 |
| Losartan | 121 | $3,515 | $29 |
| Humulin N | 21 | $3,380 | $161 |
| Qvar | 30 | $2,539 | $85 |
| Amlodipine Besylate | 133 | $2,128 | $16 |
| Simvastatin | 127 | $2,118 | $17 |
| Gabapentin | 30 | $1,944 | $65 |
| Dilt-Xr | 26 | $1,634 | $63 |
| Allopurinol | 33 | $1,532 | $46 |
| Atenolol | 129 | $1,468 | $11 |
| Lisinopril | 120 | $1,415 | $12 |
| Hydrocodone-Acetaminophen | 41 | $1,258 | $31 |
| Propranolol | 13 | $1,232 | $95 |
| Hydralazine | 15 | $1,150 | $77 |
| Hydrochlorothiazide | 88 | $1,087 | $12 |
| Pravastatin | 21 | $890 | $42 |
| Metformin | 71 | $887 | $12 |
| Lisinopril-Hydrochlorothiazide | 77 | $874 | $11 |
| Tamsulosin | 15 | $709 | $47 |
| Metoprolol | 61 | $666 | $11 |
| Lovastatin | 55 | $636 | $12 |
| Proair Hfa | 15 | $589 | $39 |
| Alendronate | 40 | $579 | $14 |
| Nortriptyline | 37 | $554 | $15 |
| Fluticasone Propionate | 33 | $537 | $16 |
| Omeprazole | 13 | $520 | $40 |
| Ventolin Hfa | 14 | $515 | $37 |
| Trazodone | 35 | $469 | $13 |
| Glipizide | 37 | $465 | $13 |
| Furosemide | 36 | $461 | $13 |
| Prednisone | 24 | $450 | $19 |
| Famotidine | 16 | $432 | $27 |
| Pantoprazole | 16 | $387 | $24 |
| Terazosin | 24 | $347 | $14 |
| Amoxicillin | 11 | $246 | $22 |
| Metformin Hcl Er | 13 | $225 | $17 |
| Cephalexin | 20 | $212 | $11 |
| Warfarin | 15 | $208 | $14 |
| Carvedilol | 15 | $182 | $12 |
| Triamcinolone Acetonide | 13 | $152 | $12 |
| Ciprofloxacin | 11 | $129 | $12 |
| Azithromycin | 11 | $97 | $9 |
2015: 45 drugs
| Spiriva | 17 | $11,673 | $687 |
| Aggrenox | 12 | $7,988 | $666 |
| Levothyroxine | 114 | $4,115 | $36 |
| Atorvastatin | 108 | $3,462 | $32 |
| Losartan | 110 | $3,307 | $30 |
| Amlodipine Besylate | 128 | $3,086 | $24 |
| Qvar | 31 | $3,018 | $97 |
| Lantus | 13 | $2,935 | $226 |
| Humulin N | 20 | $2,533 | $127 |
| Dulera | 11 | $2,459 | $224 |
| Simvastatin | 125 | $2,134 | $17 |
| Humulin R | 23 | $2,123 | $92 |
| Hydrocodone-Acetaminophen | 46 | $1,566 | $34 |
| Atenolol | 133 | $1,551 | $12 |
| Fluticasone Propionate | 69 | $1,495 | $22 |
| Gabapentin | 17 | $1,451 | $85 |
| Lisinopril | 124 | $1,417 | $11 |
| Oxycodone-Acetaminophen | 11 | $1,381 | $126 |
| Dilt-Xr | 21 | $1,339 | $64 |
| Pravastatin | 24 | $1,304 | $54 |
| Allopurinol | 29 | $1,293 | $45 |
| Proair Hfa | 28 | $1,057 | $38 |
| Hydrochlorothiazide | 82 | $986 | $12 |
| Omeprazole | 24 | $915 | $38 |
| Lisinopril-Hydrochlorothiazide | 70 | $797 | $11 |
| Lovastatin | 66 | $770 | $12 |
| Propranolol | 13 | $769 | $59 |
| Metformin | 59 | $739 | $13 |
| Metoprolol | 65 | $714 | $11 |
| Pantoprazole | 21 | $690 | $33 |
| Nortriptyline | 38 | $652 | $17 |
| Insulin | 14 | $609 | $44 |
| Glipizide | 41 | $531 | $13 |
| Alendronate | 37 | $523 | $14 |
| Furosemide | 38 | $502 | $13 |
| Hydrocortisone | 11 | $498 | $45 |
| Prednisone | 17 | $397 | $23 |
| Terazosin | 26 | $374 | $14 |
| Pramipexole Dihydrochloride | 16 | $288 | $18 |
| Trazodone | 23 | $268 | $12 |
| Warfarin | 18 | $258 | $14 |
| Azithromycin | 20 | $247 | $12 |
| Triamcinolone Acetonide | 14 | $200 | $14 |
| Fluoxetine | 11 | $180 | $16 |
| Ciprofloxacin | 16 | $162 | $10 |
2014: 47 drugs
| Aggrenox | 11 | $6,648 | $604 |
| Lantus | 14 | $4,997 | $357 |
| Losartan | 103 | $2,937 | $29 |
| Atorvastatin | 85 | $2,737 | $32 |
| Levothyroxine | 109 | $2,694 | $25 |
| Amlodipine Besylate | 116 | $2,594 | $22 |
| Simvastatin | 129 | $2,267 | $18 |
| Zostavax | 11 | $2,035 | $185 |
| Qvar | 23 | $1,887 | $82 |
| Exforge | 11 | $1,856 | $169 |
| Fluticasone Propionate | 84 | $1,850 | $22 |
| Pravastatin | 23 | $1,650 | $72 |
| Atenolol | 144 | $1,649 | $11 |
| Oxycodone-Acetaminophen | 11 | $1,411 | $128 |
| Lisinopril | 124 | $1,408 | $11 |
| Hydrocodone-Acetaminophen | 82 | $1,327 | $16 |
| Dilt-Xr | 17 | $1,146 | $67 |
| Humulin N | 12 | $1,136 | $95 |
| Gabapentin | 17 | $1,101 | $65 |
| Pantoprazole | 31 | $1,087 | $35 |
| Humulin R | 13 | $1,063 | $82 |
| Hydrochlorothiazide | 85 | $1,017 | $12 |
| Omeprazole | 26 | $977 | $38 |
| Lovastatin | 82 | $959 | $12 |
| Proair Hfa | 26 | $887 | $34 |
| Propranolol | 19 | $779 | $41 |
| Metformin | 63 | $773 | $12 |
| Allopurinol | 21 | $624 | $30 |
| Lisinopril-Hydrochlorothiazide | 52 | $613 | $12 |
| Nortriptyline | 31 | $589 | $19 |
| Metoprolol | 51 | $572 | $11 |
| Insulin | 13 | $516 | $40 |
| Triamcinolone Acetonide | 18 | $460 | $26 |
| Glipizide | 35 | $435 | $12 |
| Alendronate | 28 | $402 | $14 |
| Ropinirole | 11 | $385 | $35 |
| Furosemide | 27 | $367 | $14 |
| Terazosin | 26 | $360 | $14 |
| Fluoxetine | 13 | $238 | $18 |
| Warfarin | 17 | $231 | $14 |
| Azithromycin | 17 | $197 | $12 |
| Ibuprofen | 11 | $191 | $17 |
| Trazodone | 19 | $177 | $9 |
| Isosorbide Mononitrate Er | 14 | $175 | $12 |
| Prednisone | 12 | $168 | $14 |
| Citalopram Hbr | 12 | $133 | $11 |
| Ciprofloxacin | 17 | $130 | $8 |
2013: 50 drugs
| Aggrenox | 12 | $6,203 | $517 |
| Zostavax | 20 | $3,560 | $178 |
| Levothyroxine | 105 | $2,823 | $27 |
| Losartan | 79 | $2,602 | $33 |
| Amlodipine Besylate | 105 | $2,468 | $24 |
| Simvastatin | 111 | $2,270 | $20 |
| Atorvastatin | 74 | $2,259 | $31 |
| Colcrys | 14 | $2,109 | $151 |
| Gabapentin | 16 | $1,742 | $109 |
| Humulin R | 17 | $1,724 | $101 |
| Humulin N | 19 | $1,603 | $84 |
| Omeprazole | 40 | $1,527 | $38 |
| Atenolol | 125 | $1,511 | $12 |
| Fluticasone Propionate | 67 | $1,498 | $22 |
| Hydrocodone-Acetaminophen | 92 | $1,470 | $16 |
| Pravastatin | 26 | $1,410 | $54 |
| Dilt-Xr | 18 | $1,335 | $74 |
| Lidoderm | 12 | $1,207 | $101 |
| Lovastatin | 96 | $1,099 | $11 |
| Lisinopril | 87 | $1,018 | $12 |
| Hydrochlorothiazide | 83 | $967 | $12 |
| Qvar | 13 | $966 | $74 |
| Pantoprazole | 22 | $924 | $42 |
| Desonide | 12 | $911 | $76 |
| Proair Hfa | 27 | $810 | $30 |
| Allopurinol | 24 | $768 | $32 |
| Propranolol | 17 | $749 | $44 |
| Metformin | 52 | $676 | $13 |
| Lisinopril-Hydrochlorothiazide | 51 | $591 | $12 |
| Alendronate | 37 | $588 | $16 |
| Hydrocortisone | 12 | $570 | $47 |
| Ropinirole | 15 | $566 | $38 |
| Tamsulosin | 15 | $524 | $35 |
| Quetiapine | 12 | $482 | $40 |
| Metoprolol | 42 | $430 | $10 |
| Glipizide | 36 | $418 | $12 |
| Insulin | 14 | $417 | $30 |
| Terazosin | 29 | $405 | $14 |
| Nortriptyline | 26 | $401 | $15 |
| Pramipexole Dihydrochloride | 12 | $398 | $33 |
| Isosorbide Mononitrate Er | 13 | $388 | $30 |
| Furosemide | 25 | $376 | $15 |
| Klor-Con | 11 | $371 | $34 |
| Prednisone | 16 | $352 | $22 |
| Warfarin | 17 | $238 | $14 |
| Azithromycin | 18 | $211 | $12 |
| Latanoprost | 12 | $204 | $17 |
| Citalopram Hbr | 11 | $158 | $14 |
| Risperidone | 11 | $152 | $14 |
| Ciprofloxacin | 20 | $151 | $8 |
Money from drug and device companies
$445 in 2025
| 2025 | 7 | 14 | None | $445 |
| 2024 | 2 | 2 | None | $36 |
| 2023 | 3 | 4 | None | $91 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Freestyle Libre 3 | $147 | 1 payment
|
| Amgen | Evenity | $106 | 4 payments
|
| Exact Sciences | The Cologuard Plus Collection Kit | $65 | 3 payments
|
| Lilly USA | Mounjaro | $53 | 3 payments
|
| Scpharmaceuticals | Furoscix | $30 | 1 payment
|
| Heartflow | Ffrct | $25 | 1 payment
|
See all 14 published payments
| Scpharmaceuticals | Meals · 2025-11-17 | Furoscix | $30 |
| Lilly USA | Meals · 2025-10-21 | Mounjaro | $19 |
| Amgen | Meals · 2025-10-14 | Evenity | $27 |
| Exact Sciences | Meals · 2025-10-13 | The Cologuard Plus Collection Kit | $22 |
| Amgen | Meals · 2025-10-06 | Evenity | $27 |
| Lilly USA | Meals · 2025-08-18 | Mounjaro | $19 |
| Abbott Laboratories | Meals · 2025-07-24 | Freestyle Libre 3 | $147 |
| Exact Sciences | Meals · 2025-07-14 | The Cologuard Plus Collection Kit | $21 |
| Amgen | Meals · 2025-05-16 | Evenity | $28 |
| Lilly USA | Meals · 2025-05-12 | Zepbound | $15 |
| Exact Sciences | Meals · 2025-04-14 | The Cologuard Plus Collection Kit | $22 |
| Amgen | Meals · 2025-03-10 | Evenity | $25 |
| Heartflow | Meals · 2025-02-28 | Ffrct | $25 |
| Philips North America | Meals · 2025-02-03 | Vest Therapy Und | $19 |
See earlier years (2024, 2023)
2024: $36
| Pfizer | Paxlovid | $18 | 1 payment
|
| Lilly USA | Mounjaro | $17 | 1 payment
|
2023: $91
| GlaxoSmithKline | Shingrix | $46 | 2 payments
|
| Novo Nordisk | None | $24 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $21 | 1 payment
|
Professional record
- NPI
- 1013120260
- Licence
- CA A102994California A102994: Current · expires 2027-04-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 2490 Hospital Drive, Suite 212, Mountain View, CA, 94040
- NPI first listed
- 2007-05-07
- NPI last updated
- 2022-12-13
- NPI record certified
- 2022-12-13
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.